Satelia

Industry
Telemedicine
Founded Year
2017
Headquarters
Bordeaux, France
Employee Count
100

Key People

Assessment

Team
Aspect: First-time physician innovator
Summary: Founded by a physician with clinical experience.

The CEO, Dr. Nicolas Pags, is an anesthesiologist who founded Satelia in 2017. While his medical background provides a strong understanding of clinical needs, the lack of prior entrepreneurial experience could pose challenges in scaling the business.

Clinical Need
Aspect: Very Strong
Summary: Addresses a critical need in chronic disease management.

Chronic heart failure affects millions globally, leading to frequent hospitalizations and significant healthcare expenditures. Remote monitoring solutions like Satelia's can improve patient outcomes and reduce costs, addressing a substantial clinical need.

Competition
Aspect: Somewhat crowded
Summary: Operates in a competitive telemedicine market.

The telemedicine industry has seen rapid growth, with many companies offering remote monitoring solutions. Satelia must differentiate itself through unique features, superior outcomes, or strategic partnerships to gain a competitive edge.

Technical Challenge
Aspect: Predictable
Summary: Utilizes established technologies for remote monitoring.

Satelia's platform leverages existing technologies for data collection and communication, minimizing technical uncertainties. This predictability facilitates smoother development and deployment processes.

Patent
Aspect: Applied
Summary: Limited information on proprietary technology.

A strong patent portfolio can protect innovations and provide a competitive edge. The lack of detailed information on Satelia's patents makes it difficult to assess this aspect fully.

Financing
Aspect: Well-funded
Summary: Secured significant funding to support growth.

In October 2022, Satelia secured 10 million in Series A funding from Impact Partners. This capital infusion supports product development, market expansion, and operational scaling.

Regulatory
Aspect: 510k/PMA + Reimbursement
Summary: Achieved regulatory approval and reimbursement in France.

Satelia's remote monitoring solutions have obtained CE marking, indicating compliance with European health and safety standards. Additionally, the French Social Security system reimburses these services, facilitating adoption among healthcare providers.

Opportunity Rollup

Odds of Success
3.15
Peak Market Share
4.4
Segment CAGR
3.6%
Market Segment
Telemedicine
Market Sub Segment
Remote Patient Monitoring
Year Post Launch Market Penetration (%)
1 0.22
2 0.66
3 1.54
4 3.08
5 4.40

Key Takeaway

Satelia addresses a critical need in chronic disease management with its remote monitoring solutions, but must navigate a competitive market and expand its regulatory approvals to achieve broader success.